• About
• Links
• Contact
• Sitemap
• 

Patient Monitoring Markets

Patient monitoring is vital to care in operating rooms, emergency rooms, intensive care units and critical care units. It has proven invaluable for respiratory therapy, recovery rooms, outpatient care, transport, radiology, catheterization laboratories and gastroenterology departments, as well as for ambulatory, home and sleep screening applications.

Patient monitoring can reduce the risk of infection and other complications, and it can assist in providing for patient comfort. Moreover, patient monitoring products measure, display and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices.

The qualifier “at regular intervals over time” is used to distinguish patient monitoring devices from diagnostic kits and devices, which are typically used once or a few times to diagnose a patient’s condition and/or plan a course of therapy.

Measured parameters include electrocardiogram (ECG), invasive and noninvasive blood pressure, pulse rate, pulse oximetry, body temperature, respiration rate, end-tidal CO2 and other specialized parameters. Products vary from specialized single-parameter instruments to monitors with the ability to measure multiple parameters and interface with other instruments.

This report:

• Assesses the patient monitoring device market drivers and bottlenecks from the perspective of medical and manufacturer communities
• Discusses the potential benefits of the patient monitoring device market for various sectors of the medical community
• Establishes the current total market size and future growth of the patient monitoring device market and analyzes the current size and growth of various segments
• Provides current and forecasted market shares by the company
• Provides strategic recommendations for near-term business opportunities and assesses current commercial uses of the patient monitoring market.

Table of Contents

TABLE OF CONTENTS

1. Introduction 11

• 1.1 Objectives of this Report 11
• 1.2 Scope of this Report 11
• 1.3 Methodology 12
• 1.4 Executive Summary 13
  • 1.4.1 The U.S. Medical Device Market 13
  • 1.4.2 Supply and Demand Fundamentals 13
  • 1.4.3 Sector Convergence 14
  • 1.4.4 Future Forecast 14
• 1.5 The Leader in Patient Monitors 22
• 1.6 U.S. Market for Patient Monitors 22
• 1.7 Indian Market for Patient Monitors 22
• 1.8 South East Asia’s Patient Monitoring Market 23

2. Market for Diabetes Monitoring 25

• 2.1 Market for Blood Glucose Meters and Test Strips 27
• 2.2 U.S. Market for Diabetes Care 28
• 2.3 Self Monitoring Blood Glucose (SMBG) Device Market in Asia-Pacific 29
• 2.4 Reviews of the Latest Glucose Meters 30
  • 2.4.1 Abbott Glucose Meters 30
  • 2.4.2 Glucose Meters from Bayer Healthcare 35
  • 2.4.3 Glucose Meters from LifeScan 40
  • 2.4.4 Glucose Meters from Roche 46
  • 2.4.5 Glucose Meters from Home Diagnostics 49

3. Sleep Market 57

• 3.1 Sleep-Disordered Breathing (SDB) and Sleep Apnea 57
• 3.2 Existing Therapies for Sleep Apnea 58
• 3.3 Market for Sleep Apnea 58
• 3.4 ResMed Corporation’s Sleep Business 59
  • 3.4.1 Airflow Generators 59
  • 3.4.2 ResMed’s Mask Systems and Diagnostic Products 61
  • 3.4.3 ResMed’s Competitors 64
• 3.5 Pictorial Profile of a Few Sleep Products from ResMed 64
• 3.6 Sleep Products from Philips Respironics, Inc. 70
• 3.7 The Awakening of the Sleep Market 73
• 3.8 New Investment in Sleep Apnea by GE and Intel 74

4. Pulse Oximetry 75

• 4.1 Pulse Oximeters from Nellcor 77
• 4.2 Pulse Oximeters from GE Healthcare 79
• 4.3 Pulse Oximeters from Criticare Systems, Inc. 80
• 4.4 Pulse Oximeters from Masimo Corporation 81
• 4.5 Pulse Oximeters from Nihon Kohden 83
• 4.6 Pulse Oximeters from Nonin Medical, Inc. 84
• 4.7 An Estimation of Pulse Oximetry Gap 85

5. Capnography Market 86

• 5.1 New Trends in Capnography 87
• 5.2 European Market for Critical Care Blood Gas Monitoring 89
• 5.3 Oridion and Capnography 89
• 5.4 Philips Respironics and Capnography 91
• 5.5 Smith Medical and Capnography 92
• 5.6 Nonin Medical and Capnography 93

6. Anesthesia Monitors 94

• 6.1 European Anesthesia Equipment Market 94
• 6.2 The Sluggish Western European Market 95
• 6.3 Sustained Growth in Eastern European Market 95
• 6.4 Price Sensitivity 95
• 6.5 Fierce Competition 95
• 6.6 Fast Growth for Depth of Anesthesia Monitors 96
• 6.7 Demands for Clinical Application Suites 96
• 6.8 Hospital IT Aids Market Penetration of AIMS 96
• 6.9 Future of Anesthesia Equipment Market in the E.U. 96
• 6.10 Anesthesia Monitors from Dräger 97
• 6.11 Anesthesia Monitors from GE Healthcare 99
• 6.12 Anesthesia Monitors from Aspect Medical Systems 101
• 6.13 Anesthesia Monitors from Mindray 102

7. Fetal Monitors 104

• 7.1 Fetal Monitors from Analogic Corporation 105
• 7.2 Fetal Monitors from GE Healthcare 105
• 7.3 Fetal Monitor from Philips Healthcare 107
• 7.4 Fetal Monitor from Cardinal Health 108
• 7.5 Fetal Monitor from Nonin Medical 108
• 7.6 Fetal Monitor from Spacelab Healthcare 109

8. Global Cardiovascular Devices Market 110

• 8.1 Cardiovascular Monitoring 110
  • 8.1.1 Global Market for Ultrasound Devices 110
  • 8.1.2 Cardiovascular Diseases in the U.S. 111
  • 8.1.3 Market for Electrophysiology Devices in the U.S. 112
  • 8.1.4 Cardiovascular Diseases in Europe 113
  • 8.1.5 Cardiovascular Diseases in India 114
• 8.2 Cardiology Equipment Market in India 114
• 8.3 Cardiovascular Monitors from Biosense Webster (Johnson & Johnson) 116
• 8.4 Cardiovascular Monitors from Boston Scientific 117
• 8.5 Cardiovascular Monitor from Pulsion Medical Systems 117
• 8.6 Cardiovascular products from GE Healthcare 118

9. Market for External Defibrillators 120

• 9.1 Defibrillation 120
• 9.2 Performance of Defibrillation 120
• 9.3 Challenges Related to Defibrillation 120
• 9.4 Types of Defibrillators 121
• 9.5 Defibrillators from Cardiac Science Corporation 122
• 9.6 Defibrillators from Physio-Control, Inc. 124

10. Blood Pressure Monitors 127

• 10.1 A&D Medical/Life Source 127
• 10.2 Omron Healthcare Co., Ltd. 132
• 10.3 Japan Precision Instruments, Inc. 132
• 10.4 Mabis Healthcare Duro-Med Industries (DMI) 135
• 10.5 Medisana AG 136
• 10.6 American Diagnostic Corporation 137

11. Holter Monitors 138

• 11.1 Holter Monitors from Braemar, Inc. 138
• 11.2 Holter Monitors from Fukuda Denshi 140
• 11.3 Holter Monitor from Mortara Instrument 141
• 11.4 Holter Monitor from Philips Healthcare 141
• 11.5 Holter Monitor from Spacelab Healthcare 142
• 11.6 Holter Monitor from Schiller AG 142

12. Market for Temperature Monitoring 143

13. Telehealth Market 144

• 13.1 Intel and GE in Telehealth 145
  • 13.1.1 Usage of Remote Patient Monitoring in U.S. Healthcare Organizations in 2009 146
• 13.2 Philips Healthcare 147
• 13.3 Telehealth and Troubled Pregnancies 148
• 13.4 Telehealth Devices from Tunstall 148

14. High Acuity Areas Monitoring Systems 151

• 14.1 Patient Monitoring Systems in the High Acuity Area 151
• 14.2 Advantages 151
• 14.3 Market Scene 152
• 14.4 Technology Trends 153
• 14.5 Key Players 153
• 14.6 Future of High Acuity Patient Monitors 154
• 14.7 Product Profiles from Selected Companies 154

15. Global Home Healthcare Market 171

• 15.1 Home Healthcare Market in the U.S. 171
• 15.2 Wireless Monitoring in Home Healthcare 173

16. Profiles of Top 30 Medical Device Companies 177

• 16.1 Johnson & Johnson 177
  • 16.1.1 Johnson & Johnson’s Consumer Healthcare Business 177
  • 16.1.2 Johnson & Johnson’s Medical Devices and Diagnostics Business 177
  • 16.1.3 Johnson & Johnson’s Pharmaceutical Business 178
  • 16.1.4 Research and Development 178
• 16.2 GE Healthcare 179
  • 16.2.1 GE Healthcare’s Surgery Business 179
  • 16.2.2 GE Healthcare’s Healthcare Systems Business 179
  • 16.2.3 GE Healthcare’s Life Sciences Business 180
  • 16.2.4 GE Healthcare’s Medical Diagnostics Business 180
  • 16.2.5 GE Healthcare’s Healthcare IT Business 180
• 16.3 Siemens Healthcare 180
• 16.4 Medtronic 183
  • 16.4.1 Medtronic’s Cardiac Rhythm Disease Management (CRDM) 183
  • 16.4.2 Medtronic’s Spinal Products 184
  • 16.4.3 Medtronic’s Cardiovascular Products 184
  • 16.4.4 Medtronic’s Neuromodulation Products 185
  • 16.4.5 Medtronic’s Diabetes Products 185
  • 16.4.6 Medtronic’s Surgical Technologies Products 185
  • 16.4.7 Medtronic’s Performance in the U.S. and Non-U.S. markets 186
• 16.5 Cardinal Health 187
  • 16.5.1 Cardinal’s Healthcare Supply Chain Services Business 187
  • 16.5.2 Cardinal’s Clinical and Medical Products Business 188
• 16.6 Baxter International 189
  • 16.6.1 Baxter’s Bioscience Business 189
  • 16.6.2 Baxter’s Medication Delivery Business 189
  • 16.6.3 Baxter’s Renal Business 190
  • 16.6.4 Baxter’s Global Performance 190
• 16.7 Philips Healthcare 191
  • 16.7.1 Philips’ Cardiology Solutions 192
  • 16.7.2 Philips’ Oncology Solutions 192
  • 16.7.3 Philips’ Women’s Health Solutions 192
  • 16.7.4 Philips’ Healthcare Performance 192
• 16.8 Boston Scientific 193
• 16.9 Covidien 197
• 16.10 Becton Dickinson and Company 199
• 16.11 Abbot Laboratories 202
• 16.12 Stryker 205
  • 16.12.1 Hip Implant Systems 207
  • 16.12.2 Knee Implant Systems 207
  • 16.12.3 Trauma Implant Systems 207
  • 16.12.4 Spinal Implant Systems 207
  • 16.12.5 Craniomaxillofacial Implant Systems 207
  • 16.12.6 Surgical Equipment and Surgical Navigation Systems 208
  • 16.12.7 Endoscopic, Communications and Digital Imaging Systems 208
  • 16.12.8 Patient Handling and Emergency Medical Equipment 208
• 16.13 B. Braun 208
• 16.14 3M Healthcare 212
• 16.15 Zimmer Holdings 213
• 16.16 St. Jude Medical 215
  • 16.16.1 Atrial Fibrillation at St. Jude 216
  • 16.16.2 Connectivity at St. Jude 216
  • 16.16.3 Neuromodulation at St. Jude 216
• 16.17 Hospira, Inc. 219
  • 16.17.1 Hospira’s Devices 219
• 16.18 Smith & Nephew 221
  • 16.18.1 Smith & Nephew’s Orthopedics 222
  • 16.18.2 Smith & Nephew’s Endoscopy 222
  • 16.18.3 Smith & Nephew’s Advanced Wound Management 222
  • 16.18.4 Smith & Nephew’s R&D 222
• 16.19 Danaher 224
  • 16.19.1 Danaher’s Medical Technologies 224
• 16.20 Synthes 226
• 16.21 Beckman Coulter, Inc. 227
• 16.22 Olympus Medical Systems 229
• 16.23 Fresenius Medical Care 231
• 16.24 Alcon 234
• 16.25 Terumo Cardiovascular Systems 238
  • 16.25.1 Terumo’s General Hospital Products Segment 238
  • 16.25.2 Terumo’s Cardiac and Vascular Products Segment 239
  • 16.25.3 Terumo’s Home Healthcare Products 239
  • 16.25.4 Terumo’s Performance in Geographic Segments 240
  • 16.25.5 Terumo’s R&D Programs 241
• 16.26 C.R. Bard, Inc. 242
  • 16.26.1 Bard’s Vascular Products 242
  • 16.26.2 Bard’s Urology Products 243
  • 16.26.3 Bard’s Oncology Products 243
  • 16.26.4 Bard’s Surgical Specialties 244
• 16.27 Oridion Medical 245
  • 16.27.1 Oridion’s Leadership in Capnography 245
  • 16.27.2 Smart Capnography 246
  • 16.27.3 Oridion’s Performance 247
• 16.28 DENTSPLY International, Inc. 248
  • 16.28.1 DENTSPLY’s Products 249
• 16.29 Dräger Medical AG & Co. 250
• 16.30 Varian Medical Systems, Inc. 252
  • 16.30.1 Varian’s Oncology Systems 252
  • 16.30.2 Varian’s X-ray Products 253
  • 16.30.3 Varian’s R&D 254

17. The Invincible Medical Device Industry 256

• 17.1 Baby Boomers and Incubating Innovations 256
• 17.2 The Medical Device Industry in 2009 256
• 17.3 Global Outlook for Medical Devices 257
• 17.4 Outlook for Medical Devices in India 259
  • 17.4.1 Interventional Cardiology Market in India 261
  • 17.4.2 Molecular Diagnostics Market in India 262
  • 17.4.3 Penetration of Cardiology Informatics in India 263
• 17.5 Outlook for Medical Devices in Russia 264
• 17.6 Outlook for Medical Devices in China 265
  • 17.6.1 Penetration of Radiology Informatics in China 266
  • 17.6.2 In Vitro Diagnostics Market in China 266
  • 17.6.3 Impact of Recent Regulations in China 268
  • 17.6.4 Demand for High-end Products in China 268
  • 17.6.5 Forming Partnership with Chinese Companies 270
• 17.7 South East Asia’s X-ray Market 270
• 17.8 South East Asia’s Ultrasound Market 271
• 17.9 Outlook for Medical Devices in Malaysia 273
• 17.10 Outlook for Medical Devices in Indonesia 274
  • 17.10.1 Diagnostic Imaging Market in Indonesia 274
• 17.11 Outlook for Medical Devices in Singapore 275
• 17.12 Outlook for Medical Devices in Vietnam 276
• 17.13 Outlook for Medical Devices in Denmark 276
• 17.14 Outlook for Medical Devices in the U.K. 277

 

• Appendix 1: The Global Medical Device Market 278
• Appendix 1.1: Medical Device Market: U.S. 278
• Appendix 1.2: Medical Device Market: France 279
• Appendix 1.3: Medical Device Market: Turkey 280
• Appendix 1.4: Medical Device Market: Romania 281
• Appendix 2: Merger and Acquisition (M&A) in Medical Device Sector 283
• Appendix 3: The Attractive Market for Investment 284
• Appendix 3.1: Domination of Orthopedics 284
• Appendix 3.2: Focus on Ophthalmic 284
• Appendix 3.3: Patient Monitoring Portfolios 285
• Appendix 3.4: Biosurgery and Wound care 285
• Appendix 3.5: Cardiology Sector with a Healthy Heartbeat 286
• Appendix 3.6: Deals in Diagnostics and Analytics 286
• Appendix 3.7: Activities among Components Companies 287
• Appendix 3.8: Future M&A Activity 287
• Appendix 4: MDEA Award Winners and Patient Monitoring Products, 2008 and 2009 289
• Appendix 5: Medical Equipment Market Trends in 2009 295
• Appendix 5.1: Stellar Growth for Healthcare Information Technology 295
• Appendix 5.2: Home Healthcare Equipment Market Poised for a Big Return 295
• Appendix 5.3: Ongoing Trend towards Medical Tourism 296
• Appendix 5.4: Medical Equipment Manufacturers Remain Stable Defying Recession 297
• Appendix 5.5: Direct To Consumer Advertising Increases 297
• Appendix 5.6: Healthcare Information Technology to Gain Attention in Emerging Economies 298
• Appendix 5.7: Drug Eluting Stents on a Comeback Trail in the U.S. 298
• Appendix 5.8: Hip Resurfacing Market to Get a Boost from Young Adults and Middle-aged Patients 298
• Appendix 5.9: Cash Rich and Innovative Companies to Thrive in the Present Economic Scenario 298
• Appendix 5.10: Products for Women’s Health, Minimally Invasive Surgery and Home Healthcare to Gain 298
• Appendix 5.11: High Value and Low Value of Deals will be a Norm in M&A 299

INDEX OF FIGURES

• Figure 1.1: Global Market for Patient Monitors, 2008-2015 14
• Figure 1.2: U.S. Market for Patient Monitors, 2008-2015 15
• Figure 1.3: Global Market Share for Patient Monitors by Company, 2007 16
• Figure 1.4: Global Share of Patient Monitoring Market by Philips, 2007 16
• Figure 1.5: Philips’ Global Market Share in Patient Monitors, 2003-2007 17
• Figure 1.6: GE’s Global Market Share in Patient Monitors, 2003-2007 18
• Figure 1.7: Dräger’s Global Market Share in Patient Monitors, 2003-2007 19
• Figure 1.8: Mindray’s Global Market Share in Patient Monitors, 2003-2007 20
• Figure 1.9: Nihon Kohden’s Global Market Share in Patient Monitors, 2003-2007 21
• Figure 1.10: Nihon Kohden’s Market for Patient Monitors, 2008 21
• Figure 1.11: South East Asia’s Patient Monitor Market, 2007 24
• Figure 2.1: The Global Diabetes Care Devices Market, 2008-2015 26
• Figure 2.2: Prevalence of Diabetes in the Top Three Diabetic Countries, 2007 and 2025 27
• Figure 2.3: Total Economic Cost of Diabetes in the U.S., 2007 28
• Figure 2.4: Asia-Pacific SMBG Competitive Market Share, 2007 29
• Figure 2.5: Chinese SMBG Competitive Market Share, 2007 30
• Figure 2.6: Bayer’s Market for Diabetes Care Segment, 2006-2008 35
• Figure 2.7: Johnson & Johnson’s Market in Diabetes Care, 2008 40
• Figure 2.8: Roche’s Market in Diabetes Care Segment, 2008 46
• Figure 2.9: Home Diagnostics’ Market for Glucose Meters and Accessories, 2005-2008 49
• Figure 3.1: Global Sleep Apnea Management Market, 2008-2012 59
• Figure 3.2: ResMeds’s Market for CPAP and VPAP Flow Generators, 2006-2008 59
• Figure 3.3: ResMed’s Market for Masks and Accessories, 2006-2008 61
• Figure 3.4: ResMed’s Market for its Sleep Products in the Americas, 2006-2008 63
• Figure 3.5: ResMed’s Market for its Sleep Products in Europe, 2006-2008 63
• Figure 3.6: ResMed’s Market in Asia-Pacific and Rest of the World, 2006-2008 64
• Figure 4.1: U.S. Pulse Oximetry Market Share by Company, 2008 75
• Figure 4.2: Market Growth for U.S. Pulse Oximetry, 2008-2013 76
• Figure 4.3: Market for Pulse Oximeters in the E.U., 2008-2015 77
• Figure 4.4: Nellcor’s (Covidien) Market for Oximetry and Monitoring Products, 2006-2008 77
• Figure 4.5: Masimo SET Installed Base, 2004-2008 81
• Figure 5.1: E.U. Market for Critical Care Blood Gas Monitoring Products, 2008-2013 89
• Figure 5.2: Oridion’s Capnography Market, 2004-2008 90
• Figure 6.1: Global Anesthesia and Respiratory Devices Market, 2008-2015 94
• Figure 6.2: Aspect’s Worldwide Total Installed Bases of Monitors and Modules, 2004-2008 101
• Figure 6.3: Aspect’s Sensor Shipment, 2004-2008 102
• Figure 8.1: Global Market for Cardiovascular Devices, 2008-2012 110
• Figure 8.2: Global Market for Ultrasound Devices, 2008-2015 111
• Figure 8.3: Direct and Indirect Costs of Heart Diseases in the U.S., 2009 112
• Figure 8.4: U.S. Electrophysiology Device Market in the U.S., 2008-2015 112
• Figure 8.5: European Market for Electrocardiography Products, 2008 113
• Figure 8.6: Mortality Rate for CVD, 2007 114
• Figure 8.7: Indian ECG Equipment Market by Unit, 2008 115
• Figure 8.8: Indian ECG Equipment Market by Value, 2008 115
• Figure 8.9: Boston’s Cardiology Market, 2008 117
• Figure 8.10: Pulsion’s Dominance in Intensive Care Unit in Comparison to Competitors, 2008 118
• Figure 9.1: Growth of Manual External Defibrillators, 2008-2012 123
• Figure 9.2: Cardiac Science’s Market for Defibrillation Products, 2006-2008 124
• Figure 13.1: Growth of Telehealth, 2010-2015 144
• Figure 13.2: Telehealth Market, 2008-2012 145
• Figure 13.3: Growth of Telehealth as Predicted by Intel and GE, 2008-2012 146
• Figure 13.4: Remote Patient Monitoring in the U.S. Healthcare Organizations, 2009 146
• Figure 14.1: Market Share of Multiparameter Monitoring Equipments by Company, 2008 153
• Figure 14.2: Market Share Split among the Key Players in High Acuity Area Patient Monitors, 2008 154
• Figure 15.1: Global Home Healthcare Market, 2008-2012 171
• Figure 15.2: U.S. Market for Home Healthcare Products, 2008-2012 172
• Figure 15.3: Patients Diagnosed with Common Welfare Diseases in Europe and the U.S., 2008 174
• Figure 15.4: Global Blood Pressure Monitoring Market, 2008-2012 174
• Figure 15.5: Global Blood Glucose Monitoring Market, 2008-2012 175
• Figure 15.6: Global Lipid Monitoring Market, 2008-2012 175
• Figure 16.1: Johnson & Johnson’s Consumer Segment Performance, 2008 177
• Figure 16.2: Johnson & Johnson’s Medical Devices and Diagnostics Performance, 2008 178
• Figure 16.3: Johnson & Johnson’s Pharmaceutical Business Performance, 2008 178
• Figure 16.4: Johnson & Johnson’s R&D Expenditure, 2006-2008 179
• Figure 16.5: GE Healthcare’s Performance, 2004-2008 180
• Figure 16.6: Siemens’ Business Performance in Healthcare Segment by Geography, 2008 181
• Figure 16.7: Siemens’ Business Performance in Healthcare Sector by Segment, 2008 182
• Figure 16.8: Medtronic’s Cardiac Rhythm Disease Management Performance, 2008 184
• Figure 16.9: Medtronic’s Spine Products Performance, 2008 184
• Figure 16.10: Medtronic’s Cardiovascular Products Performance, 2008 185
• Figure 16.11: Medtronic’s Surgical Technologies Products Performance, 2008 186
• Figure 16.12: Medtronic’s U.S. and Non-U.S. Performance, 2008 186
• Figure 16.13: Cardinal’s Overall Performance, 2006-2008 187
• Figure 16.14: Cardinal’s Healthcare Supply Chain Services Performance, 2006-2008 188
• Figure 16.15: Cardinal’s Clinical and Medical Products Performance, 2007 and 2008 188
• Figure 16.16: Baxter’s Bioscience Business Performance, 2008 189
• Figure 16.17: Baxter’s Medication Delivery Business Performance, 2008 190
• Figure 16.18: Baxter’s Renal Business Performance, 2008 190
• Figure 16.19: Baxter’s Global Performance, 2006-2008 191
• Figure 16.20: Philips’ Healthcare Performance, 2006-2008 193
• Figure 16.21: Philips Healthcare Performance by Geography, 2008 193
• Figure 16.22: Boston’s Global Performance, 2004-2008 194
• Figure 16.23: Boston’s Performance in Cardiac Rhythm Management, 2007 and 2008 194
• Figure 16.24: Boston’s Performance in Coronary Stent Systems, 2007 and 2008 195
• Figure 16.25: Boston’s Performance in Endosurgery, 2007 and 2008 196
• Figure 16.26: Boston’s Global Performance by Geography, 2006-2008 196
• Figure 16.27: Covidien’s Global Performance, 2004-2008 197
• Figure 16.28: Covidien’s R&D Expenditure, 2004-2008 198
• Figure 16.29: Covidien’s Performance by Geographical Region, 2008 198
• Figure 16.30: Covidien’s Performance in Medical Devices by Groups of Products, 2008 199
• Figure 16.31: BD’s Global Performance, 2005-2008 200
• Figure 16.32: BD’s Medical Segment: Performance by Sub-Segment, 2008 200
• Figure 16.33: BD’s Diagnostic Segment: Performance, 2007 and 2008 201
• Figure 16.34: BD’s Biosciences Segment: Performance, 2007 and 2008 201
• Figure 16.35: BD’s U.S. and Non-U.S. Performance, 2008 202
• Figure 16.36: Abbott’s Global Performance, 2004-2008 203
• Figure 16.37: Abbott’s Performance: Vascular Segment, 2006-2008 203
• Figure 16.38: Abbott’s Performance: Diagnostics Segment, 2006-2008 204
• Figure 16.39: Abbott’s Performance: Pharmaceutical Segment, 2006-2008 204
• Figure 16.40: Abbott’s Performance: Nutritional Segment, 2006-2008 205
• Figure 16.41: Abbott’s R&D Expenditure, 2006-2008 205
• Figure 16.42: Stryker’s Global Performance, 2006-2008 206
• Figure 16.43: Stryker’s R&D Expenditure, 2006-2008 207
• Figure 16.44: B. Braun’s Group Performance, 2006-2008 209
• Figure 16.45: B. Braun’s Performance: Hospital Care Division, 2006-2008 209
• Figure 16.46: B. Braun’s Performance: Aesculap Division, 2006-2008 210
• Figure 16.47: B. Braun’s Performance: OPM Division, 2006-2008 210
• Figure 16.48: B. Braun’s Performance: Avitum Division, 2006-2008 211
• Figure 16.49: B. Braun’s Employees by Region, 2008 212
• Figure 16.50: 3M Healthcare: Global Performance, 2006-2008 213
• Figure 16.51: Zimmer’s Global Performance, 2006-2008 214
• Figure 16.52: Zimmer’s Performance by Geographic Segment, 2008 214
• Figure 16.53: Zimmer’s R&D Expenditure, 2006-2008 215
• Figure 16.54: St. Jude’s Global Performance, 2006-2008 215
• Figure 16.55: St. Jude’s Performance in Cardiac Rhythm Management, 2008 217
• Figure 16.56: St. Jude’s Performance in its Cardiovascular Segment, 2008 217
• Figure 16.57: St. Jude’s Performance in Atrial Fibrillation Products, 2006-2008 218
• Figure 16.58: St. Jude’s Performance in Neuromodulation Products, 2006-2008 218
• Figure 16.59: Hospira’s Global Performance, 2004-2008 219
• Figure 16.60: Hospira’s Performance in the Americas, 2008 220
• Figure 16.61: Hospira’s Performance in EMEA Region, 2008 220
• Figure 16.62: Hospira’s Performance in APAC Region, 2008 221
• Figure 16.63: Hospira’s R&D Investment, 2006-2008 221
• Figure 16.64: Smith & Nephew’s R&D Expenditure, 2006-2008 223
• Figure 16.65: Smith & Nephew’s Performance by Business Segment, 2008 223
• Figure 16.66: Smith & Nephew’s Performance by Geographic Market, 2008 224
• Figure 16.67: Danaher’s Performance by Geography, 2008 224
• Figure 16.68: Danaher’s R&D Expenditure in its Medical Technologies, 2006-2008 225
• Figure 16.69: Medical Technologies Performance: U.S. and Non-U.S., 2006-2008 225
• Figure 16.70: Danaher’s Performance in Medical Technologies, 2006-2008 226
• Figure 16.71: Synthes’ Global Performance, 2004-2008 227
• Figure 16.72: Synthes’ Performance by Geographical Region, 2008 227
• Figure 16.73: Beckman Coulter’s Global Performance, 2004-2008 228
• Figure 16.74: Beckman Coulter’s Performance by Geographic Region, 2008 228
• Figure 16.75: Olympus’ Global Performance, 2004-2008 229
• Figure 16.76: Olympus’ Performance by Geographic Area, 2008 230
• Figure 16.77: Olympus’ Performance by Business Segments, 2008 230
• Figure 16.78: Fresenius’ Group Performance, 2004-2008 231
• Figure 16.79: Fresenius’ Performance by Geographic Region, 2008 232
• Figure 16.80: Fresenius’ Performance in Dialysis Products, 2007 and 2008 233
• Figure 16.81: Fresenius Kabi’s Performance by Geographic Region, 2008 234
• Figure 16.82: Alcon Laboratory’s Global Performance, 2004-2008 234
• Figure 16.83: Alcon Laboratory’s Performance by Geographical Segment, 2008 235
• Figure 16.84: Alcon Laboratory’s R&D Expenditure, 2004-2008 235
• Figure 16.85: Alcon’s R&D Expenditure by Therapeutic Category, 2008 236
• Figure 16.86: Alcon’s Global Surgical Market Share, 2004-2008 236
• Figure 16.87: Alcon’s Global Market Share in Intraocular Lenses, 2004-2008 237
• Figure 16.88: Alcon’s U.S. Contact Lens Care Solution Market Share, 2008 237
• Figure 16.89: Terumo’s Performance: General Hospital Products Segment, 2004-2008 238
• Figure 16.90: Terumo’s Performance: Cardiac and Vascular Products, 2004-2008 239
• Figure 16.91: Terumo’s Performance: Home Healthcare Products, 2004-2008 240
• Figure 16.92: Terumo’s Performance by Geographical Region, 2008 241
• Figure 16.93: Terumo’s R&D Expenditure, 2004-2008 241
• Figure 16.94: Bard’s Performance in Vascular Products, 2004-2008 242
• Figure 16.95: Bard’s Performance in Urology Products, 2004-2008 243
• Figure 16.96: Bard’s Performance in Oncology Products, 2004-2008 244
• Figure 16.97: Bard’s Performance in Surgical Specialties, 2004-2008 245
• Figure 16.98: Capnography Boards Sold by Oridion, 2004-2008 246
• Figure 16.99: Oridion’s Performance, 2004-2008 247
• Figure 16.100: Oridion’s Investment in R&D, 2006-2008 248
• Figure 16.101: DENTSPLY’s Performance by Geographic Segment, 2008 249
• Figure 16.102: DENTSPLY’s Global Performance, 2004-2008 250
• Figure 16.103: Drager’s Performance by Region, 2008 251
• Figure 16.104: Drager’s Business Performance in its Medical Division, 2008 251
• Figure 16.105: Drager’s Medical Division R&D Expenditure, 2004-2008 252
• Figure 16.106: Varian’s Performance in its Oncology Systems, 2006-2008 253
• Figure 16.107: Performance of Varian’s Oncology Systems, 2008 253
• Figure 16.108: Varian’s Performance in its X-ray Products, 2006-2008 254
• Figure 16.109: Performance of Varian’s X-ray Products by Geographic Region, 2008 254
• Figure 16.110: Varian’s R&D Expenditure, 2006-2008 255
• Figure 17.1: Global Market for Medical Devices, 2008-2011 257
• Figure 17.2: Market Growth for Medical Devices in India, 2008-2015 260
• Figure 17.3: Market Growth for Cardiovascular Devices in India, 2008-2015 260
• Figure 17.4: Market Growth for Orthopedic Devices in India, 2008-2015 261
• Figure 17.5: Interventional Cardiology Market in India, 2008-2012 262
• Figure 17.6: Indian Molecular Diagnostics Instruments and Reagent Market, 2008 263
• Figure 17.7: Penetration of Cardiology Informatics in India, 2008 264
• Figure 17.8: Growth of Market for Medical Devices in Russia, 2008-2013 264
• Figure 17.9: Market Growth for Medical Devices in China, 2008-2013 265
• Figure 17.10: The Market for Radiology IT in China, 2008 266
• Figure 17.11: In Vitro Diagnostic Market in China, 2007-2010 267
• Figure 17.12: China’s In Vitro Diagnostic Market Value, 2007 267
• Figure 17.13: The Top Three Deadly Diseases in China, 2009 269
• Figure 17.14: South East Asia’s X-ray Market, 2007 271
• Figure 17.15: Growth of Ultrasound Market in South East Asia, 2007-2010 272
• Figure 17.16: South East Asia’s Ultrasound Market Value, 2007 272
• Figure 17.17: Percentage of Color Versus Black & White Units Installed in South East Asia, 2007 273
• Figure 17.18: Market Growth for Medical Devices in Malaysia, 2008-2010 273
• Figure 17.19: Market Growth for Medical Devices in Indonesia, 2008-2013 274
• Figure 17.20: Indonesia’s Diagnostic Imaging Market, 2008 275
• Figure 17.21: Market Growth for Medical Devices in Singapore, 2008-2012 275
• Figure 17.22: Market Growth for Medical Devices in Vietnam, 2009-2014 276
• Figure 17.23: Market Growth for Medical Devices in Denmark, 2009-2014 277
• Figure 17.24: Market Growth for Medical Devices in the U.K., 2009-2014 277
• Figure A1.1: U.S. Medical Device Exports, 2008 278
• Figure A1.2: Total U.S. Medical Device Exports, 2007 279
• Figure A1.3: Growth of Medical Device Market: France, 2008-2013 279
• Figure A1.4: Export of Medical Devices from Turkey by Value, 2004-2008 280
• Figure A1.5: Medical Device Market Growth: Romania, 2008-2013 281
• Figure A5.1: U.S. Market Growth in Healthcare IT, 2007-2012 295
• Figure A5.2: Growth of Global Home Healthcare Equipment Market, 2007-2012 296
• Figure A5.3: Growth for Indian Medical Tourism, 2007-2012 296

INDEX OF TABLES

• Table 2.1: Technical Information on FreeStyle Lite 32
• Table 2.2: Technical Information for Freedom Lite 33
• Table 2.3: Technical Information on Precision Xtra 35
• Table 2.4: Technical Information for Contour 37
• Table 2.5: Technical Information on Contour TS 38
• Table 2.6: Technical Information on Breeze2 39
• Table 2.7: Technical Information on OneTouch Ultra Mini 41
• Table 2.8: Technical Information on OneTouch Ultra2 43
• Table 2.9: Technical Information on OneTouch UltraSmart 44
• Table 2.10: Technical Information on OneTouch UltraLink 45
• Table 2.11: Technical Information on Accu-Chek Compact Plus 47
• Table 2.12: Technical Information on Accu-Chek Aviva 49
• Table 2.13: Technical Information on True2Go 51
• Table 2.14: Technical Information on TRUEresult 52
• Table 2.15: Technical Information on TRUEtrack 53
• Table 2.16: Technical Information on TRUEread 54
• Table 2.17: Technical Information on Sidekick 56
• Table 3.1: ResMed’s Continuous Positive Airway Products 60
• Table 3.2: ResMed’s Automatic Positive Airway Products 60
• Table 3.3: ResMed’s Variable Positive Airway Products 60
• Table 3.4: ResMed’s Ventilation Products 61
• Table 3.5: ResMed’s Mask Systems and Diagnostic Products 62
• Table 3.6: Sleep Recorders from ResMed 62
• Table 4.1: Pulse Oximetry Market Estimate 85
• Table 16.1: Fresenius’ Medical Care in Asia, 2007 and 2008 232
• Table 16.2: APP Pharmaceuticals Statistics, 2008 232
• Table 17.1: Leading Global Medical Device Companies, 2008 258
• Table A1.1: Turkish Medical Devices Export by Product Groups, 2003-2008 281
• Table A2.1: Merger and Acquisition in Medical Device Sector, 2008 283
• Table A5.1: Comparison of Cost for Medical Procedures 297

Other users found this report page using the following search terms: electrocardiogram ecg critical care patient monitoring intensive care itu Oximetry market monitoring patient monitor india medical share size monitors blood

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.

Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.